Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors Meeting Abstract
| Authors: | Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; Scaltriti, M.; Solit, D. B.; Robson, M. E.; Reis-Filho, J. S.; Jhaveri, K. L.; Chandarlapaty, S. |
| Abstract Title: | Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 37s |
| Language: | English |
| ACCESSION: | WOS:000487345803656 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.1009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1009 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
